Literature DB >> 25423998

HIV-1 subtype diversity based on envelope C2V3 sequences from Kenyan patients on highly active antiretroviral therapy.

Rose C Kitawi1, Timothy Nzomo, Ruth S Mwatelah, Rashid Aman, Maureen J Kimulwo, Geoffrey Masankwa, Raphael M Lwembe, Javan Okendo, Bernhards Ogutu, Washingtone Ochieng.   

Abstract

There is a continuous need to genetically characterize the HIV strains in circulation in order to assess interventions and inform vaccine discovery. We partially sequenced the envelope C2V3 gene from a total of 59 Kenyan patients on highly active antiretroviral treatment (HAART) and determined HIV subtypes using both the JPHMM subtyping tool and the phylogenetic method. HIV-1 subtype A1 was the predominant strain in circulation, representing 65.5% and 74.5% of all isolates as determined by JPHMM and phylogenetic methods, respectively. Subtypes C and D were the next most prevalent pure strains at 9.1% each by both methods. JPHMM identified 9.1% of the isolates as recombinant. Four isolates had short sequences not covering the entire C2V3 region and were thus not subtyped. From this study, subtype A viruses are still the predominant HIV-1 strains in local circulation in Kenya. Constant surveillance is needed to update molecular trends under continuing HAART scale-up.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25423998     DOI: 10.1089/aid.2014.0306

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  5 in total

1.  Genotypic Variability of HIV-1 Reverse Transcriptase Gene from Long-Term Antiretroviral-Experienced Patients in Kenya.

Authors:  Timothy J Nzomo; Rose C Kitawi; Ruth S Mwatelah; Rashid Aman; Maureen J Kimulwo; Geoffrey Masankwa; Javan Okendo; Raphael M Lwembe; Bernhards Ogutu; Anne Muigai; Washingtone Ochieng
Journal:  AIDS Res Hum Retroviruses       Date:  2015-03-31       Impact factor: 2.205

2.  Comparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children.

Authors:  Matilda Chelimo Saina; Xiuqiong Bi; Raphael Lihana; Raphael Lwembe; Azumi Ishizaki; Annie Panikulam; Tresa Palakudy; Rachel Musoke; Mary Owens; Elijah Maritim Songok; Hiroshi Ichimura
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

3.  Co-Infection Burden of Hepatitis C Virus and Human Immunodeficiency Virus among Injecting Heroin Users at the Kenyan Coast.

Authors:  Ruth S Mwatelah; Raphael M Lwembe; Saida Osman; Bernhards R Ogutu; Rashid Aman; Rose C Kitawi; Laura N Wangai; Florence A Oloo; Gilbert O Kokwaro; Washingtone Ochieng
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

4.  Partial HIV C2V3 envelope sequence analysis reveals association of coreceptor tropism, envelope glycosylation and viral genotypic variability among Kenyan patients on HAART.

Authors:  Rose C Kitawi; Carol W Hunja; Rashid Aman; Bernhards R Ogutu; Anne W T Muigai; Gilbert O Kokwaro; Washingtone Ochieng
Journal:  Virol J       Date:  2017-02-14       Impact factor: 4.099

5.  Plasma nevirapine concentrations predict virological and adherence failure in Kenyan HIV-1 infected patients with extensive antiretroviral treatment exposure.

Authors:  Maureen J Kimulwo; Javan Okendo; Rashid A Aman; Bernhards R Ogutu; Gilbert O Kokwaro; Dorothy J Ochieng; Anne W T Muigai; Florence A Oloo; Washingtone Ochieng
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.